Kayne Anderson Rudnick Investment Management
UTHR icon

Kayne Anderson Rudnick Investment Management’s United Therapeutics UTHR Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08K Hold
2
– – ﹤0.01% 884
2026
Q1 		$1.19K Hold
2
– – ﹤0.01% 830
2025
Q4 		$975 Hold
2
– – ﹤0.01% 878
2025
Q3 		$838 Hold
2
– – ﹤0.01% 901
2025
Q2 		$575 Buy
+2
New +$598 ﹤0.01% 977
2024
Q4 		– Sell
-35
Closed -$12.5K – 1029
2024
Q3 		$12.5K Buy
+35
New +$11.8K ﹤0.01% 653
2022
Q2 		– Sell
-11
Closed -$2K – 685
2022
Q1 		$2K Buy
+11
New +$2.1K ﹤0.01% 607

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Kayne Anderson Rudnick Investment Management's UTHR Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 2 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #884.

Kayne Anderson Rudnick Investment Management first reported a position in UTHR in Q1 2022 and has held it in 7 quarters since. The position peaked at $12.5K in Q3 2024. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 2 shares of United Therapeutics worth $1.08K as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #884 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in United Therapeutics in Q1 2022 and has held it in 7 quarters since.
  • Kayne Anderson Rudnick Investment Management's United Therapeutics position peaked at $12.5K in Q3 2024.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.